RVP Logo

RVP Stock Forecast: Retractable Technologies Inc. Price Predictions for 2026

Home โ€บ Stocks โ€บ United States | NYSE | Healthcare | Medical Instruments & Supplies

$0.73

+0.02 (2.82%)

RVP Stock Forecast 2026-2027

$0.73
Current Price
$21.85M
Market Cap
0 Ratings
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings

Distance to RVP Price Targets

N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A

RVP Price Momentum

-5.2%
1 Week Change
-11.0%
1 Month Change
-7.6%
1 Year Change
-5.2%
Year-to-Date Change
-36.0%
From 52W High of $1.14
+17.7%
From 52W Low of $0.62
๐Ÿ“Š TOP ANALYST CALLS

Did RVP Make This Month's Elite Buy List?

We don't follow just any analyst โ€” only the top 3% with a proven track record make our cut. See if Retractable Technologies is one of their latest high-conviction picks.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Latest RVP Stock Price Targets & Analyst Predictions

RVP has shown a year-to-date change of -5.2% and a 1-year change of -7.6%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for RVP. Please refer to the price chart above for recent performance and trends.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

RVP Analyst Ratings

0
Buy
0
Hold
0
Sell

RVP Price Target Range

Low
N/A
Average
N/A
High
N/A
Current: $0.73

Latest RVP Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for RVP.

Date Firm Analyst Rating Change Price Target

Retractable Technologies Inc. (RVP) Competitors

The following stocks are similar to Retractable Technologies based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Retractable Technologies Inc. (RVP) Financial Data

Retractable Technologies Inc. has a market capitalization of $21.85M with a P/E ratio of 8.1x. The company generates $37.90M in trailing twelve-month revenue with a -17.0% profit margin.

Revenue growth is -2.5% quarter-over-quarter, while maintaining an operating margin of -36.2% and return on equity of -8.0%.

Valuation Metrics

Market Cap $21.85M
Enterprise Value $-11,179,637
P/E Ratio 8.1x
PEG Ratio -0.1x
Price/Sales 0.6x

Growth & Margins

Revenue Growth (YoY) -2.5%
Gross Margin +16.7%
Operating Margin -36.2%
Net Margin -17.0%
EPS Growth N/A

Financial Health

Cash/Price Ratio +155.3%
Current Ratio 6.7x
Debt/Equity 1.3x
ROE -8.0%
ROA -8.5%
๐Ÿ’ก SKIP THE NOISE

97% of Analyst Ratings Go Nowhere

We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ€” tracked and updated every Monday and Thursday.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Retractable Technologies Inc. logo

Retractable Technologies Inc. (RVP) Business Model

About Retractable Technologies Inc.

What They Do

Develops safety medical devices for healthcare.

Business Model

The company designs, manufactures, and markets safety medical devices, primarily retractable and injection needle systems. It generates revenue by selling these innovative products to hospitals, clinics, and other healthcare providers, focusing on minimizing risks associated with needle-stick injuries and cross-contamination.

Additional Information

Retractable Technologies Inc. is committed to improving public health and safety through its products and plays a significant role in influencing best practices in the medical device industry. The company's emphasis on technological innovation and quality positions it as a trusted partner within healthcare.

Company Information

Sector

Healthcare

Industry

Medical Instruments & Supplies

Employees

221

CEO

Mr. Thomas J. Shaw

Country

United States

IPO Year

2001

Retractable Technologies Inc. (RVP) Latest News & Analysis

Latest News

RVP stock latest news image
Quick Summary

Retractable Technologies, Inc. declared dividends of $39,050 for Series II Class B and $18,561.25 for Series III Class B Convertible Preferred Stock, payable on January 20, 2026.

Why It Matters

Retractable Technologies' dividend declaration signals financial stability and a commitment to returning value to shareholders, which can enhance investor confidence and stock demand.

Source: Business Wire
Market Sentiment: Neutral
RVP stock latest news image
Quick Summary

Retractable Technologies reported improved Q3 2025 earnings due to enhanced margins, investment gains, and a transition to domestic production.

Why It Matters

Improved earnings, better margins, and a shift to domestic production indicate stronger financial health and growth potential, positively influencing investor sentiment and stock performance.

Source: Zacks Investment Research
Market Sentiment: Positive
RVP stock latest news image
Quick Summary

Retractable Technologies' EasyPointยฎ Blood Collection Tube Holder has received an Innovative Technology designation from Vizient, highlighting its potential to enhance clinical care and safety in healthcare.

Why It Matters

Retractable Technologies' EasyPointยฎ product recognition by Vizient could boost sales and market position, signaling growth potential and innovation in the healthcare sector, attracting investor interest.

Source: Business Wire
Market Sentiment: Neutral
RVP stock latest news image
Quick Summary

Retractable Technologies, Inc. reported Q3 2025 net sales of $10.1 million and an operating loss of $3.7 million, improving from $10.3 million in sales and a $5.1 million loss last year. Year-to-date sales are $28.8 million with $13.5 million in losses.

Why It Matters

Retractable Technologies shows slight sales decline but improved operating loss, indicating potential operational efficiency. Investors may view this as a positive trend in cost management despite lower revenue.

Source: Business Wire
Market Sentiment: Neutral
RVP stock latest news image
Quick Summary

RVP reported stronger Q2 2025 sales and reduced losses, attributing the improvement to increased domestic production, which helped mitigate tariff impacts.

Why It Matters

RVP's stronger sales and reduced losses indicate improved financial health, suggesting resilience against tariffs, which could boost investor confidence and stock performance.

Source: Zacks Investment Research
Market Sentiment: Positive
RVP stock latest news image
Quick Summary

Retractable Technologies, Inc. reported Q2 2025 net sales of $10.4M and an operating loss of $5.1M, improving from $6.0M in sales and a $5.8M loss in Q2 2024. H1 2025 sales totaled $18.7M, with losses at $9.8M.

Why It Matters

Retractable Technologies shows revenue growth, increasing net sales from $6.0 million to $10.4 million, indicating potential recovery, despite ongoing operating losses.

Source: Business Wire
Market Sentiment: Neutral

Frequently Asked Questions About RVP Stock

What is Retractable Technologies Inc.'s (RVP) stock forecast for 2026?

Analyst forecasts for Retractable Technologies Inc. (RVP) are not currently available. The stock is trading at $0.73.

Is RVP stock a good investment in 2026?

Analyst ratings for RVP are not currently available. The stock is currently trading at $0.73. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.

What is the long-term price prediction for RVP stock?

Price predictions from Wall Street analysts for RVP are not currently available. The stock is trading at $0.73.

What is Retractable Technologies Inc.'s business model?

The company designs, manufactures, and markets safety medical devices, primarily retractable and injection needle systems. It generates revenue by selling these innovative products to hospitals, clinics, and other healthcare providers, focusing on minimizing risks associated with needle-stick injuries and cross-contamination.

What is the highest forecasted price for RVP Retractable Technologies Inc.?

Price targets from Wall Street analysts for RVP are not currently available. The stock is trading at $0.73.

What is the lowest forecasted price for RVP Retractable Technologies Inc.?

Price targets from Wall Street analysts for RVP are not currently available. The stock is trading at $0.73.

What is the overall RVP consensus from analysts for Retractable Technologies Inc.?

Analyst ratings for RVP are not currently available. The stock is trading at $0.73.

How accurate are RVP stock price projections?

Stock price projections, including those for Retractable Technologies Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.

Important Disclaimer

The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Last updated: January 18, 2026 9:30 AM UTC
Serious About Growing Your Portfolio?

We highlight 2 high-upside stocks each month – no fluff.

Missedย NVDA?
Donโ€™t Miss the Next One.

Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ€” for free.